secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vor Biopharma Inc. (VOR)
CIK:        0001817229
Form:       8-K
Filed at:   2024-08-30T23:59:59+00:00
Accession:  0001193125-24-211050
Event type: other_material
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Vor Biopharma receives Nasdaq deficiency notice for bid price below $1.00
-------------------------------------------------------------------------

- Nasdaq notified Vor Biopharma on Aug 29, 2024 that its common stock bid price has been below $1.00 for 30 consecutive business days.
- Company has until Feb 25, 2025 to regain compliance by closing at or above $1.00 for at least 10 consecutive business days.
- If not compliant by Feb 2025, Vor may transfer to Nasdaq Capital Market for an additional 180-day grace period, subject to other listing requirements.
- Delisting risk exists if compliance not regained or transfer not completed; company monitoring options including potential reverse stock split.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1817229/000119312524211050/0001193125-24-211050-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1817229/000119312524211050/d885644d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-211050

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer